= The information that is currently available is very scarce, since there is only a single study in two healthy volunteers in which ventilation with a face mask was applied, and therefore the applicability of the studies in practice is minimal.
= If, due to the challenges posed by the current situation, it is decided to use a respirator for ventilation of more than one patient, the following specifications should be considered to guarantee an adequate procedure:
- Ventilation of multiple ...
This evidence summary is based on a structured search of the literature and selected evidence-based health care databases. The evidence in this summary comes from:
• A systematic review of six RCTs and 23 observational studies, including two meta-analyses; one of RCTs and other of observational studies.
• A systematic review of six randomized controlled trials (RCTs) involving 9,171 participants.
• The pooled results of two RCTs: continuous use of N95 respirators (pooled data from both ...
This evidence summary is based on a structured search of the literature and selected evidence-based health care databases. The evidence in this summary comes from:
• A systematic review of six RCTs and 23 observational studies, including two meta-analyses; one of RCTs and other of observational studies.
• A systematic review of six randomized controlled trials (RCTs) involving 9,171 participants.
• The pooled results of two RCTs: continuous use of N95 respirators (pooled data from both ...
This evidence summary is based on a structured search of the literature and selected evidence-based health care databases. The evidence in this summary comes from:
• A systematic review of six RCTs and 23 observational studies, including two meta-analyses; one of RCTs and other of observational studies.
• A systematic review of six randomized controlled trials (RCTs) involving 9,171 participants.
• The pooled results of two RCTs: continuous use of N95 respirators (pooled data from both ...
Coronavirus (COVID-19): Evidence Collection. Evidence Aid
Like COVID-19, severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) are acute respiratory diseases caused by a coronavirus. Ribavirin was used to treat patients with these earlier coronaviruses and might be considered as a treatment for COVID-19.
In this systematic review, the authors searched Chinese and English literature databases for research of any design testing ribavirin as a treatment of SARS or MERS. They did their search in February 2020. They ...